POUR, Luděk, Zdeněk ADAM, Lucie BUREŠOVÁ, Marta KREJČÍ, Andrea KŘIVANOVÁ, Viera SANDECKÁ, Lenka ZAHRADOVÁ, Tomáš BÜCHLER, Jiří VORLÍČEK a Roman HÁJEK. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib. Clinical lymphoma & myeloma. Dallas, Tex. : United States: Cancer Information Group, 2009, roč. 9, č. 2, s. 151-153, 4 s. ISSN 1557-9190. |
Další formáty:
BibTeX
LaTeX
RIS
@article{830571, author = {Pour, Luděk and Adam, Zdeněk and Burešová, Lucie and Krejčí, Marta and Křivanová, Andrea and Sandecká, Viera and Zahradová, Lenka and Büchler, Tomáš and Vorlíček, Jiří and Hájek, Roman}, article_location = {Dallas, Tex. : United States}, article_number = {2}, keywords = {Varicella-zoster virus; acyclovir; multiple myeloma}, language = {eng}, issn = {1557-9190}, journal = {Clinical lymphoma & myeloma}, title = {Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib}, volume = {9}, year = {2009} }
TY - JOUR ID - 830571 AU - Pour, Luděk - Adam, Zdeněk - Burešová, Lucie - Krejčí, Marta - Křivanová, Andrea - Sandecká, Viera - Zahradová, Lenka - Büchler, Tomáš - Vorlíček, Jiří - Hájek, Roman PY - 2009 TI - Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib JF - Clinical lymphoma & myeloma VL - 9 IS - 2 SP - 151-153 EP - 151-153 PB - Cancer Information Group SN - 15579190 KW - Varicella-zoster virus KW - acyclovir KW - multiple myeloma N2 - Varicella-zoster virus (VZV) reactivation is a common complication in patients with multiple myeloma (MM) treated with bortezomib, with an incidence rate of 10%-60%. The aim of our study was to analyze the effect of acyclovir prophylaxis in this patient population. ER -
POUR, Luděk, Zdeněk ADAM, Lucie BUREŠOVÁ, Marta KREJČÍ, Andrea KŘIVANOVÁ, Viera SANDECKÁ, Lenka ZAHRADOVÁ, Tomáš BÜCHLER, Jiří VORLÍČEK a Roman HÁJEK. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib. \textit{Clinical lymphoma \&{} myeloma}. Dallas, Tex. : United States: Cancer Information Group, 2009, roč.~9, č.~2, s.~151-153, 4 s. ISSN~1557-9190.
|